Literature DB >> 23408051

Vaccination route matters for mucosal tumors.

Denise Nardelli-Haefliger1, Jan C Dudda, Pedro Romero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23408051     DOI： 10.1126/scitranslmed.3005638

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


× No keyword cloud information.
  9 in total

Review 1.  Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

Authors:  Mevyn Nizard; Mariana O Diniz; Helene Roussel; Thi Tran; Luis Cs Ferreira; Cecile Badoual; Eric Tartour
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor.

Authors:  Sonia Domingos-Pereira; Rim Hojeij; Erica Reggi; Laurent Derré; Mathieu F Chevalier; Pedro Romero; Patrice Jichlinski; Denise Nardelli-Haefliger
Journal:  Oncoimmunology       Date:  2015-05-22       Impact factor: 8.110

3.  Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.

Authors:  Yun-Yan Sun; Shiwen Peng; Liping Han; Jin Qiu; Liwen Song; Yachea Tsai; Benjamin Yang; Richard B S Roden; Cornelia L Trimble; Chien-Fu Hung; T-C Wu
Journal:  Clin Cancer Res       Date:  2015-09-29       Impact factor: 12.531

4.  Profiling cancer testis antigens in non-small-cell lung cancer.

Authors:  Dijana Djureinovic; Björn M Hallström; Masafumi Horie; Johanna Sofia Margareta Mattsson; Linnea La Fleur; Linn Fagerberg; Hans Brunnström; Cecilia Lindskog; Katrin Madjar; Jörg Rahnenführer; Simon Ekman; Elisabeth Ståhle; Hirsh Koyi; Eva Brandén; Karolina Edlund; Jan G Hengstler; Mats Lambe; Akira Saito; Johan Botling; Fredrik Pontén; Mathias Uhlén; Patrick Micke
Journal:  JCI Insight       Date:  2016-07-07

5.  Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ.

Authors:  Ruey-Shyang Soong; Liwen Song; Janson Trieu; Jayne Knoff; Liangmei He; Ya-Chea Tsai; Warner Huh; Yung-Nien Chang; Wen-Fang Cheng; Richard B S Roden; T-C Wu; Cornelia L Trimble; Chien-Fu Hung
Journal:  Clin Cancer Res       Date:  2014-06-03       Impact factor: 12.531

6.  Immunotherapeutic strategies for bladder cancer.

Authors:  Mathieu F Chevalier; Denise Nardelli-Haefliger; Sonia Domingos-Pereira; Patrice Jichlinski; Laurent Derré
Journal:  Hum Vaccin Immunother       Date:  2014-01-02       Impact factor: 3.452

7.  Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours.

Authors:  Lukasz Bialkowski; Alexia van Weijnen; Kevin Van der Jeught; Dries Renmans; Lidia Daszkiewicz; Carlo Heirman; Geert Stangé; Karine Breckpot; Joeri L Aerts; Kris Thielemans
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

Review 8.  Tumor Resident Memory T Cells: New Players in Immune Surveillance and Therapy.

Authors:  Nina Dumauthioz; Sara Labiano; Pedro Romero
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

9.  Inhibition of Orthotopic Genital Cancer Induced by Subcutaneous Administration of Human Papillomavirus Peptide Vaccine with CpG Oligodeoxynucleotides as an Adjuvant in Mice.

Authors:  Huan Wang; Yuxin Che; Yang Yang; Jinguo Suo; Xuelian Wang
Journal:  Cancer Manag Res       Date:  2021-07-12       Impact factor: 3.989
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.